We are very excited to have surpassed the 5-year milestone with the ICD and pacemaker volume and growth data set.
New York, NY (PRWEB) March 17, 2011
Guidepoint Global, LLC, a leading primary research firm serving Corporations and Buy-Side Institutional Investors, announced the five year anniversary of its Cardiac Rhythm Management Market Tracker (CRM). The CRM Market Tracker delivers monthly web-based access to business and competitive insight such as ICD and Pacemaker market share, market size and growth. “We are very excited to have surpassed the 5-year milestone with the ICD and pacemaker volume and growth data set. Over the past few years the Cardiac Rhythm Management market has experienced significant challenges and events that have been illuminated in our data,” said Brian Cosgrove, Director of Guidepoint’s Tracker Team, and the Analyst who has led Guidepoint’s CRM market coverage since its launch in January 2006.
Guidepoint’s Cardiac Rhythm Management Market Tracker aggregates monthly ICD and Pacemaker implant data reported by a same-site panel comprised of more than 1,000 electrophysiologists, non-electrophysiologist cardiologists, thoracic surgeons and other specialists, who report on behalf of more than 250 centers and account for more than 15% of estimated worldwide market demand. Since inception, Guidepoint’s CRM market size, market share and other market data has provided users with clear visibility into the market dynamics of leading ICD and Pacemaker manufacturers. Volume and growth data from Guidepoint on single chamber, dual chamber and Biventricular (Bi-V) implant data has historically been highly correlated with the product sales figures reported by leading device makers such as Boston Scientific, St. Jude and Medtronic.
In the coming months, ICD utilization data provided by US-based implanters will provide a real-world perspective on the effect of these factors on market practices. “As we continue to monitor implant volume tends in 2011 and beyond, it will be interesting to see whether the U.S. ICD market remains challenged or shows signs of rebounding, with growth rates akin to those witnessed in 2004-2005,” observed Mr. Cosgrove.
About Guidepoint Tracker
Guidepoint Global’s Tracker Solutions are longitudinal studies that equip Institutional Investors and Companies with monthly volume, market share, pricing and additional commercial insight into medical device and biopharmaceutical utilization reported by representative, same-site samples.
Guidepoint Global’s Tracker data and market models are exclusively available to clients via a secure, web-based platform.
Click here for an overview of Guidepoint Global's suite of 30 Tracker offerings.
About Guidepoint Global, LLC
Guidepoint Global is a leading primary research firm that provides on-demand access to a highly-vetted global network of industry experts. Founded in 2003, Guidepoint covers all sectors, geographies and relevant roles. Sector expertise includes Healthcare, Technology, Media, Telecommunications, Energy, Industrials, Consumer Goods & Services, and Financial Services sectors. Clients include some of the world’s leading private equity firms, multinational corporations, consulting firms and institutional investors.
Guidepoint offers primary research services with its network of Advisors via phone consultations, face-to-face meetings, custom surveys, and proprietary data products. These services, coupled with an industry-leading compliance platform, provide the insight required to make more informed and efficient business decisions.
# # #